百川股份(002455.SZ):參股公司海基新能源獲增資至7.5億元
格隆匯11月27日丨百川股份(002455.SZ)宣佈,2020年11月26日,公司與參股公司海基新能源相關股東在江陰共同簽署了《關於江蘇海基新能源股份有限公司的增資協議》,擬將海基新能源的註冊資本由6億元增加至7.5億元。
該次增資以現金方式出資認繳,公司以自有資金出資,增資後,海基新能源註冊資本由6億元變更為7.5億元,公司直接持股比例為30.07%,間接持股比例為2.20%,合計持股比例為32.27%。
公司表示,該次增資可以進一步增強海基新能源的資金實力,有利於擴大海基新能源鋰電項目產能規模,滿足海基新能源未來發展對資金的需求,對海基新能源的未來發展將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.